Company Filing History:
Years Active: 2024
Title: David Lechuga-Ballesteros: Innovator in Antibody Formulations
Introduction
David Lechuga-Ballesteros is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical research, particularly in the development of antibody formulations. With a total of 2 patents to his name, his work focuses on innovative solutions for treating asthma.
Latest Patents
David's latest patents include dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies. These formulations are designed for pulmonary delivery and aim to provide effective treatment methods for asthma. The technology relates to the use of specific antibodies that target TSLP, which plays a crucial role in the immune response.
Career Highlights
Throughout his career, David has worked with prominent companies in the pharmaceutical industry, including Medimmune Limited and AstraZeneca Pharmaceuticals LP. His experience in these organizations has allowed him to develop and refine his innovative ideas in antibody formulations.
Collaborations
David has collaborated with several professionals in his field, including Catherine Eugenie Chaillan Huntington and Susan Hoe. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David Lechuga-Ballesteros is a distinguished inventor whose work in antibody formulations has the potential to transform asthma treatment. His innovative approach and dedication to research continue to make a significant impact in the biomedical field.